Literature DB >> 18931691

JNK signaling in apoptosis.

D N Dhanasekaran1, E P Reddy.   

Abstract

Jun N-terminal kinases or JNKs play a critical role in death receptor-initiated extrinsic as well as mitochondrial intrinsic apoptotic pathways. JNKs activate apoptotic signaling by the upregulation of pro-apoptotic genes through the transactivation of specific transcription factors or by directly modulating the activities of mitochondrial pro- and antiapoptotic proteins through distinct phosphorylation events. This review analyses our present understanding of the role of JNK in apoptotic signaling and the various mechanisms by which JNK promotes apoptosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18931691      PMCID: PMC3063296          DOI: 10.1038/onc.2008.301

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  72 in total

Review 1.  Mammalian MAP kinase signalling cascades.

Authors:  L Chang; M Karin
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

Review 2.  Signal transduction by the JNK group of MAP kinases.

Authors:  R J Davis
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 3.  The apoptosome: heart and soul of the cell death machine.

Authors:  A M Chinnaiyan
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

Review 4.  Molecular mechanisms of the decision between life and death: regulation of apoptosis by apoptosis signal-regulating kinase 1.

Authors:  A Matsuzawa; H Ichijo
Journal:  J Biochem       Date:  2001-07       Impact factor: 3.387

5.  The MLK family mediates c-Jun N-terminal kinase activation in neuronal apoptosis.

Authors:  Z Xu; A C Maroney; P Dobrzanski; N V Kukekov; L A Greene
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

6.  Rapid kinetics of tBid-induced cytochrome c and Smac/DIABLO release and mitochondrial depolarization.

Authors:  Muniswamy Madesh; Bruno Antonsson; Srinivasa M Srinivasula; Emad S Alnemri; György Hajnóczky
Journal:  J Biol Chem       Date:  2001-12-06       Impact factor: 5.157

7.  Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway.

Authors:  C Tournier; P Hess; D D Yang; J Xu; T K Turner; A Nimnual; D Bar-Sagi; S N Jones; R A Flavell; R J Davis
Journal:  Science       Date:  2000-05-05       Impact factor: 47.728

8.  Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytes.

Authors:  Hiroki Aoki; Peter M Kang; James Hampe; Koichi Yoshimura; Takafumi Noma; Masunori Matsuzaki; Seigo Izumo
Journal:  J Biol Chem       Date:  2002-01-10       Impact factor: 5.157

9.  ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis.

Authors:  K Tobiume; A Matsuzawa; T Takahashi; H Nishitoh; K Morita ; K Takeda; O Minowa; K Miyazono; T Noda; H Ichijo
Journal:  EMBO Rep       Date:  2001-03       Impact factor: 8.807

10.  Cloning and expression of ZAK, a mixed lineage kinase-like protein containing a leucine-zipper and a sterile-alpha motif.

Authors:  T C Liu; C J Huang; Y C Chu; C C Wei; C C Chou; M Y Chou; C K Chou; J J Yang
Journal:  Biochem Biophys Res Commun       Date:  2000-08-11       Impact factor: 3.575

View more
  544 in total

1.  Inhibition of c-Jun kinase provides neuroprotection in a model of Alzheimer's disease.

Authors:  Steven P Braithwaite; Ralf S Schmid; Dong Ning He; Mei-Li A Sung; Seongeon Cho; Lynn Resnick; Michael M Monaghan; Warren D Hirst; Christian Essrich; Peter H Reinhart; Donald C Lo
Journal:  Neurobiol Dis       Date:  2010-05-06       Impact factor: 5.996

2.  Signaling by the engulfment receptor draper: a screen in Drosophila melanogaster implicates cytoskeletal regulators, Jun N-terminal Kinase, and Yorkie.

Authors:  John F Fullard; Nicholas E Baker
Journal:  Genetics       Date:  2014-11-12       Impact factor: 4.562

Review 3.  Cell competition and its implications for development and cancer.

Authors:  Yoichiro Tamori; Wu-Min Deng
Journal:  J Genet Genomics       Date:  2011-09-21       Impact factor: 4.275

4.  ROCK inhibitor Y-27632 increases thaw-survival rates and preserves stemness and differentiation potential of human Wharton's jelly stem cells after cryopreservation.

Authors:  Kalamegam Gauthaman; Chui-Yee Fong; Arjunan Subramanian; Arijit Biswas; Ariff Bongso
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

Review 5.  Brain endothelial cell death: modes, signaling pathways, and relevance to neural development, homeostasis, and disease.

Authors:  Maria Teresa Rizzo; H Anne Leaver
Journal:  Mol Neurobiol       Date:  2010-04-21       Impact factor: 5.590

6.  Ursolic acid induces apoptosis in human leukaemia cells and exhibits anti-leukaemic activity in nude mice through the PKB pathway.

Authors:  Ning Gao; Senping Cheng; Amit Budhraja; Ziyi Gao; Jieping Chen; E-Hu Liu; Cheng Huang; Deying Chen; Zailin Yang; Qun Liu; Ping Li; Xianglin Shi; Zhuo Zhang
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

7.  Apoptosis Repressor With Caspase Recruitment Domain Ameliorates Amyloid-Induced β-Cell Apoptosis and JNK Pathway Activation.

Authors:  Andrew T Templin; Tanya Samarasekera; Daniel T Meier; Meghan F Hogan; Mahnaz Mellati; Michael T Crow; Richard N Kitsis; Sakeneh Zraika; Rebecca L Hull; Steven E Kahn
Journal:  Diabetes       Date:  2017-07-20       Impact factor: 9.461

8.  The involvement of the mGluR5-mediated JNK signaling pathway in rats with diabetic retinopathy.

Authors:  Yan-Ni Zhu; Guo-Jin Zuo; Qi Wang; Xiao-Ming Chen; Jin-Kui Cheng; Shu Zhang
Journal:  Int Ophthalmol       Date:  2019-01-03       Impact factor: 2.031

Review 9.  Neuroprotective action of acute estrogens: animal models of brain ischemia and clinical implications.

Authors:  Tomoko Inagaki; Anne M Etgen
Journal:  Steroids       Date:  2013-02-04       Impact factor: 2.668

10.  Partial p53-dependence of anisomycin-induced apoptosis in PC12 cells.

Authors:  R Schipp; J Varga; J Bátor; M Vecsernyés; Z Árvai; M Pap; József Szeberényi
Journal:  Mol Cell Biochem       Date:  2017-04-21       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.